RCUS
Price
$8.28
Change
-$0.25 (-2.93%)
Updated
May 9 closing price
Capitalization
876.73M
81 days until earnings call
TRDA
Price
$8.38
Change
-$0.24 (-2.78%)
Updated
May 9 closing price
Capitalization
318.05M
87 days until earnings call
Ad is loading...

RCUS vs TRDA

Header iconRCUS vs TRDA Comparison
Open Charts RCUS vs TRDABanner chart's image
Arcus Biosciences
Price$8.28
Change-$0.25 (-2.93%)
Volume$1.19M
Capitalization876.73M
Entrada Therapeutics
Price$8.38
Change-$0.24 (-2.78%)
Volume$110.35K
Capitalization318.05M
RCUS vs TRDA Comparison Chart
Loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCUS vs. TRDA commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Hold and TRDA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (RCUS: $8.28 vs. TRDA: $8.38)
Brand notoriety: RCUS and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 103% vs. TRDA: 81%
Market capitalization -- RCUS: $876.73M vs. TRDA: $318.05M
RCUS [@Biotechnology] is valued at $876.73M. TRDA’s [@Biotechnology] market capitalization is $318.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 2 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • RCUS’s TA Score: 2 bullish, 5 bearish.
  • TRDA’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than RCUS.

Price Growth

RCUS (@Biotechnology) experienced а -9.21% price change this week, while TRDA (@Biotechnology) price change was -9.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

RCUS is expected to report earnings on Jul 31, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($877M) has a higher market cap than TRDA($318M). RCUS YTD gains are higher at: -44.392 vs. TRDA (-51.533). TRDA has higher annual earnings (EBITDA): 50.8M vs. RCUS (-269M). RCUS has more cash in the bank: 978M vs. TRDA (420M). TRDA (59.2M) and RCUS (60M) have identical debt. RCUS has higher revenues than TRDA: RCUS (258M) vs TRDA (211M).
RCUSTRDARCUS / TRDA
Capitalization877M318M276%
EBITDA-269M50.8M-530%
Gain YTD-44.392-51.53386%
P/E RatioN/A14.45-
Revenue258M211M122%
Total Cash978M420M233%
Total Debt60M59.2M101%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
BTC.X104696.3300001725.468800
+1.68%
Bitcoin cryptocurrency
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with APGE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-2.93%
APGE - RCUS
48%
Loosely correlated
-1.38%
XNCR - RCUS
45%
Loosely correlated
-5.23%
ACLX - RCUS
45%
Loosely correlated
+2.29%
IMNM - RCUS
45%
Loosely correlated
-3.24%
IDYA - RCUS
45%
Loosely correlated
-4.18%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-2.78%
CRNX - TRDA
55%
Loosely correlated
-6.18%
ATXS - TRDA
54%
Loosely correlated
-3.86%
RXRX - TRDA
51%
Loosely correlated
-1.37%
NTLA - TRDA
50%
Loosely correlated
-1.93%
IMNM - TRDA
50%
Loosely correlated
-3.24%
More